Literature DB >> 12063460

Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation.

Shinji Tomita1, Donald A G Mickle, Richard D Weisel, Zhi-Qiang Jia, Laura C Tumiati, Yasmin Allidina, Peter Liu, Ren-Ke Li.   

Abstract

OBJECTIVE: The study evaluated the utility of transplanting bone marrow stromal cells in a porcine myocardial infarction model.
METHODS: A myocardial infarction was created by occluding the distal left anterior descending artery in pigs with coils and Gelfoam sponge. Sternal bone marrow was aspirated, and stromal cells were cultured and induced to differentiate to a myogenic phenotype with 5-azacytidine. Four weeks after coronary artery occlusion, sestamibi technetium single-photon emission computed tomographic scans were performed, and then either a graft of 100 x 10(6) bone marrow stromal cells (n = 5, 30% labeled with bromodeoxyuridine) or culture medium (n = 6) was injected into the infarct region. Four weeks later the tomographic scans were repeated and cardiac function was assessed with pressure and volume measurements. Morphologic and histologic characteristics of the heart were also studied.
RESULTS: Histologic examination found bromodeoxyuridine-labeled cells within the infarct region in islands that had sarcomeres and Z-bands and stained positively for cardiac specific troponin I. The bone marrow stromal cell transplant sites had a greater (P <.05) capillary density than did the control sites. The tomographic scans showed that the hearts with the cell transplants had increases in stroke volume, regional perfusion, and wall motion (P <.05 for all groups) relative to the control hearts. The pressure-volume analysis showed improvement (P <.05) in end-systolic elastance and preload recruitable stroke work in the transplantation group relative to the control group. The left ventricular chamber size was smaller (P <.05) and the scar thickness was greater (P <.05) in the hearts with transplanted cells than in the control hearts (P =.06).
CONCLUSION: 5-Azacytidine-treated bone marrow stromal cells transplanted into the myocardial infarct region formed islands of cardiac-like tissue, induced angiogenesis, prevented thinning and dilatation of the infarct region, and improved regional and global contractile function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12063460     DOI: 10.1067/mtc.2002.120716

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  50 in total

Review 1.  One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues.

Authors:  Darwin J Prockop; Carl A Gregory; Jeffery L Spees
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

2.  Cardiac function in dogs with chronic Chagas cardiomyopathy undergoing autologous stem cell transplantation into the coronary arteries.

Authors:  Marlos G Sousa; Daniel Paulino-Junior; João P E Pascon; Gláucia B Pereira-Neto; Roberta Carareto; Tatiana Champion; Aparecido A Camacho
Journal:  Can Vet J       Date:  2011-08       Impact factor: 1.008

3.  Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI).

Authors:  J Ge; Y Li; J Qian; J Shi; Q Wang; Y Niu; B Fan; X Liu; S Zhang; A Sun; Y Zou
Journal:  Heart       Date:  2006-06-14       Impact factor: 5.994

4.  Biomimetic matrices for myocardial stabilization and stem cell transplantation.

Authors:  Samuel T Wall; Che-Chung Yeh; Richard Y K Tu; Michael J Mann; Kevin E Healy
Journal:  J Biomed Mater Res A       Date:  2010-09-28       Impact factor: 4.396

Review 5.  Stem cells in the heart: what's the buzz all about? Part 2: Arrhythmic risks and clinical studies.

Authors:  Rachel Ruckdeschel Smith; Lucio Barile; Elisa Messina; Eduardo Marbán
Journal:  Heart Rhythm       Date:  2008-02-15       Impact factor: 6.343

6.  The antiapoptotic effect of mesenchymal stem cell transplantation on ischemic myocardium is enhanced by anoxic preconditioning.

Authors:  Aina He; Yun Jiang; Chun Gui; Yong Sun; Jiahui Li; Jian-an Wang
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

7.  Autologous bone marrow cell transplantation combined with off-pump coronary artery bypass grafting in patients with ischemic cardiomyopathy.

Authors:  Kyung-Jong Yoo; Hyun-Ok Kim; Young-Lan Kwak; Seok-Min Kang; Yang-Soo Jang; Sang-Hyun Lim; Ki-Chul Hwang; Seung-Woo Cho; Yoon-Sun Yang; Ren-Ke Li; Byung-Soo Kim
Journal:  Can J Surg       Date:  2008-08       Impact factor: 2.089

8.  Points to Consider in Designing Mesenchymal Stem Cell-Based Clinical Trials.

Authors:  Gary Brooke; Tony Rossetti; Nina Ilic; Patricia Murray; Sonia Hancock; Rebecca Pelekanos; Kerry Atkinson
Journal:  Transfus Med Hemother       Date:  2008-07-21       Impact factor: 3.747

Review 9.  Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation.

Authors:  Husnain Kh Haider; Muhammad Ashraf
Journal:  J Mol Cell Cardiol       Date:  2008-05-10       Impact factor: 5.000

10.  Human spongiosa mesenchymal stem cells fail to generate cardiomyocytes in vitro.

Authors:  Svetlana Mastitskaya; Bernd Denecke
Journal:  J Negat Results Biomed       Date:  2009-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.